Formoterol as reliever medication in asthma: a post-hoc analysis of the subgroup of the RELIEF study in East Asia

被引：0
|
作者：
Qi Jian Cheng
Shao-Guang Huang
Yu Zhi Chen
Jiang-Tao Lin
Xin Zhou
Bao-Yuan Chen
Yu-Lin Feng
Xia Ling
Malcolm R. Sears
机构：
[1] Shanghai Jiao Tong University,Department of Pulmonary Disease, Ruijin Hospital
[2] Capital Institute of Pediatrics,Department of Respiratory Diseases
[3] China-Japan Friendship Hospital,Department of Respiratory Medicine
[4] Shanghai First People’s Hospital,Department of Respiratory Disease
[5] Shanghai Jiao Tong University,Department of Respiratory Medicine
[6] Tianjin Medical University General Hospital,Medical and Regulatory Affairs
[7] West China Hospital,Michael G DeGroote School of Medicine, Faculty of Health Sciences
[8] Sichuan University,undefined
[9] AstraZeneca China,undefined
[10] McMaster University,undefined
来源：
BMC Pulmonary Medicine | / 16卷
关键词：
Asthma; Beta-agonist; Bronchodilator; Formoterol; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] APPaRENT 1 & 2 surveys: post-hoc analysis to assess predictors of asthma treatment adherence
    Canonica, Giorgio Walter
    Domingo, Christian
    Lavoie, Kim
    Kaliasethi, Amrit
    Khan, Shireen Quli
    Majumdar, Anurita
    Fulmali, Sourabh
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [32] Predictors of loss of asthma control in the Phase 2a INCONTRO trial: A post-hoc analysis
    Palmer, Robert
    Almquist, Joachim
    Hashemi, Mahdi
    Taib, Ziad
    Necander, Sofia
    Korsback, Katarina
    Aurell, Malin
    Asimus, Sara
    Delaney, Stephen
    Pardali, Katerina
    Gustafson, Per
    Sethi, Tariq
    Keeling, David
    Psallidas, Ioannis
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [33] Benralizumab in Patients With Severe Eosinophilic Asthma With and Without Chronic Rhinosinusitis With Nasal Polyps: An ANANKE Study post-hoc Analysis
    D'Amato, Maria
    Menzella, Francesco
    Altieri, Elena
    Bargagli, Elena
    Bracciale, Pietro
    Brussino, Luisa
    Caiaffa, Maria Filomena
    Canonica, Giorgio Walter
    Caruso, Cristiano
    Centanni, Stefano
    De Michele, Fausto
    Di Marco, Fabiano
    Pastorello, Elide Anna
    Pelaia, Girolamo
    Rogliani, Paola
    Romagnoli, Micaela
    Schino, Pietro
    Senna, Gianenrico
    Vultaggio, Alessandra
    Ori, Alessandra
    Simoni, Lucia
    Boarino, Silvia
    Vitiello, Gianfranco
    Aliani, Maria
    Del Giacco, Stefano
    FRONTIERS IN ALLERGY, 2022, 3
  • [34] Benefits of budesonide/glycopyrronium/formoterol fumarate dihydrate triple therapy versus dual therapies in patients with COPD and additional asthma features: Post-hoc analysis of KRONOS and ETHOS
    Seki, Munehiro
    Muro, Shigeo
    Hurst, John R.
    Petullo, David
    Darken, Patrick
    Megally, Ayman
    Patel, Mehul
    RESPIROLOGY, 2023, 28 : 126 - 127
  • [35] Optimization of acute medication use following eptinezumab initiation during a migraine attack: post hoc analysis of the RELIEF study
    Cady, Roger
    Lipton, Richard B.
    Buse, Dawn C.
    Josiassen, Mette Krog
    Lindsten, Annika
    Ettrup, Anders
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (01):
  • [36] Optimization of acute medication use following eptinezumab initiation during a migraine attack: post hoc analysis of the RELIEF study
    Roger Cady
    Richard B. Lipton
    Dawn C. Buse
    Mette Krog Josiassen
    Annika Lindsten
    Anders Ettrup
    The Journal of Headache and Pain, 2022, 23
  • [37] Aspirin Is Beneficial in Hypertensive Patients With Chronic Kidney Disease A Post-Hoc Subgroup Analysis of a Randomized Controlled Trial
    Jardine, Meg J.
    Ninomiya, Toshiharu
    Perkovic, Vlado
    Cass, Alan
    Turnbull, Fiona
    Gallagher, Martin P.
    Zoungas, Sophia
    Lambers Heerspink, Hiddo J.
    Chalmers, John
    Zanchetti, Alberto
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (12) : 956 - 965
  • [38] A post-hoc subgroup analysis of outcomes in the first phase III clinical study of edaravone (MCI-186) in amyotrophic lateral sclerosis
    Abe, Koji
    Itoyarna, Yasuto
    Tsuji, Shoji
    Sobue, Gen
    Aoki, Masashi
    Doyu, Manabu
    Hamada, Chikuma
    Togo, Masanori
    Yoneoka, Takatomo
    Tanaka, Masahiko
    Akimotot, Makoto
    Nakamura, Kazue
    Takahashi, Fumihiro
    Kondo, Kazuoki
    Yoshino, Hiide
    AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2017, 18 : 11 - 19
  • [39] WHO BENEFITS MOST FROM COLLABORATIVE DEMENTIA CARE? A POST-HOC SUBGROUP COST-EFFECTIVENESS ANALYSIS
    Raedke, A.
    Hoffmann, W.
    Michalowsky, B.
    VALUE IN HEALTH, 2019, 22 : S412 - S412
  • [40] Fingolimod effect on disability progression in primary progressive multiple sclerosis patients with inflammatory activity: A post-hoc subgroup analysis of the INFORMS study
    Wolinsky, J. S.
    Cree, B. A. C.
    Freedman, M. S.
    Hartung, H. -P.
    Lublin, F.
    Miller, D. H.
    Montalban, X.
    Uitdehaag, B.
    Weiner, H.
    Lubetzki, C.
    Putzki, N.
    Li, B.
    Haring, D. A.
    Merschhemke, M.
    Kappos, L.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 679 - 680
12345